Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Solifenacin (5mg)
Therapeutic Category
Urology, Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹330/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Empowering Bladder Control with Precision: The Uropair Approach Soliturn 5 (Solifenacin Succinate 5mg) represents the pinnacle of our Uropair division's commitment to specialized urological care. As a selective muscarinic M3 receptor antagonist, Soliturn 5 is specifically engineered to address the complexities of Overactive Bladder (OAB). By targeting the detrusor muscle’s stability, it provides a clinical solution for patients struggling with involuntary contractions, effectively reducing the daily burden of urinary urgency and frequenc
Empowering Bladder Control with Precision: The Uropair Approach
Soliturn 5 (Solifenacin Succinate 5mg) represents the pinnacle of our Uropair division's commitment to specialized urological care. As a selective muscarinic M3 receptor antagonist, Soliturn 5 is specifically engineered to address the complexities of Overactive Bladder (OAB). By targeting the detrusor muscle’s stability, it provides a clinical solution for patients struggling with involuntary contractions, effectively reducing the daily burden of urinary urgency and frequenc
At Cafoli Lifecare, we understand that urology requires a higher standard of purity and efficacy. That is why Soliturn 5 is manufactured in world-class WHO-GMP certified facilities, ensuring that every tablet delivers consistent pharmacokinetic performance. For our PCD Pharma partners, Soliturn 5 offers a high-demand, monopoly-based molecule that strengthens any urology portfolio. Key Therapeutic Indications: Management of urge incontinence. Reduction of increased urinary frequency (pollakisuria). Treatment of urgency symptoms associated with OAB syndrome. By integrating Soliturn 5 into your practice or distribution network, you are choosing a product backed by transparent ethical policies and the specialized expertise of the Uropair division—where nephrology and urology meet advanced pharmaceutical science.
At Cafoli Lifecare, we understand that urology requires a higher standard of purity and efficacy. That is why Soliturn 5 is manufactured in world-class WHO-GMP certified facilities, ensuring that every tablet delivers consistent pharmacokinetic performance. For our PCD Pharma partners, Soliturn 5 offers a high-demand, monopoly-based molecule that strengthens any urology portfolio.
Key Therapeutic Indications:
Management of urge incontinence.
Reduction of increased urinary frequency (pollakisuria).
Treatment of urgency symptoms associated with OAB syndrome.
By integrating Soliturn 5 into your practice or distribution network, you are choosing a product backed by transparent ethical policies and the specialized expertise of the Uropair division—where nephrology and urology meet advanced pharmaceutical science.
Common side effects may include dry mouth, constipation, blurred vision, and urinary retention. Consult a doctor if severe side effects occur.
Soliturn 5 Tablet is indicated for the treatment of overactive bladder syndrome with symptoms such as urinary urgency, frequency, and incontinence.
Use with caution in patients with a history of urinary retention, glaucoma, or gastrointestinal disorders. Consult your healthcare provider before use if pregnant or breastfeeding.
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Composition : Solifenacin (10mg) Tablet
Composition : Mirabegron (50mg) + Solifenacin (5mg)
Composition : Mirabegron (50mg)
Composition : Mirabegron (25mg)
Composition : Ivermectin (6mg) + Albendazole (400mg)
Composition : Ivermectin (12mg) Tablet
Composition : Isoxsuprine (40mg) Tablet
Composition : Tofacitinib (5mg)
Composition : Leflunomide (20mg)
Composition : Leflunomide (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Solifenacin 5mg Tablet has strong demand in the urology, nephrology, and urinary tract disorder segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on bladder and urinary care portfolios.
Medical distributors and agencies can benefit from consistent demand for overactive bladder and urinary incontinence management under medical supervision. Solifenacin 5mg is an antimuscarinic agent that helps reduce bladder muscle overactivity Commonly prescribed for overactive bladder (OAB), urinary urgency, increased frequency of urination, and urge incontinence Helps improve bladder control and reduces sudden urges to urinate Improves quality of life in patients with urinary dysfunction Widely prescribed by urologists, nephrologists, and general physicians This strengthens a comprehensive urology and urinary care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Solifenacin 5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady prescription demand in urology clinics, chronic therapy usage, repeat orders, reliable supply chain support, and attractive margins in the urinary care segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.